Product Information
TUSNEL-DM PED 2.5-25-1.25 MG/ML is a generic product labeled by Llorens Pharmaceutical International Division, priced at $0.2752 per ML under NDC 54859060601. Its NADAC has been published 42 times since Dec 17, 2025.
Strength
2.5; 25; 1.25 mg/mL; mg/mL; mg/mL
Manufacturer
Llorens Pharmaceutical International DivisionNDC
54859060601
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/1/2019
Pharmacological Classes
Price Statistics
The NADAC for TUSNEL-DM PED 2.5-25-1.25 MG/ML has been published 42 times since Dec 17, 2025, and over the history we have for it it has declined 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2752 per ML |
|---|---|
| All-time high | $0.2931 (Aug 12, 2026) |
| All-time low | $0.2752 (Sep 23, 2026) |
| 52-week high | $0.2931 |
| 52-week low | $0.2752 |
| Median price | $0.2843 |
| Average price | $0.2848 |
| Largest weekly change | -3.3% (Sep 23, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Llorens Pharmaceutical International Division manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TUSNEL-DM PED 2.5-25-1.25 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for TUSNEL-DM PED 2.5-25-1.25 MG/ML, manufactured by Llorens Pharmaceutical International Division, is $0.2752 per ML (NDC 54859060601), effective Sep 30, 2026.
How has the price of TUSNEL-DM PED 2.5-25-1.25 MG/ML changed over time?
Over the history we have for it, the NADAC for TUSNEL-DM PED 2.5-25-1.25 MG/ML has declined 3.2%. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for TUSNEL-DM PED 2.5-25-1.25 MG/ML?
Since Dec 17, 2025, the NADAC for TUSNEL-DM PED 2.5-25-1.25 MG/ML has ranged from a low of $0.2752 (Sep 23, 2026) to a high of $0.2931 (Aug 12, 2026), with a median of $0.2843 per ML.
Are there cheaper alternatives to TUSNEL-DM PED 2.5-25-1.25 MG/ML?
No other NADAC-published product currently shares the active ingredient and strength of TUSNEL-DM PED 2.5-25-1.25 MG/ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TUSNEL-DM PED 2.5-25-1.25 MG/ML?
TUSNEL-DM PED 2.5-25-1.25 MG/ML (NDC 54859060601) is labeled by Llorens Pharmaceutical International Division, and CMS classifies it as a generic product.